Sanofi (Genzyme Flanders)

Cipalstraat 8

2440 Geel

BE

Sanofi (Genzyme Flanders)

Foundation date

30/10/2001

Sector

#Biotechnology - Therapeutics

As the specialty care global business unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.

Upcoming events

Latest news

  • Newly discovered protein blocks sleeping sickness

    Wednesday February 28th 2024

  • DONESTA┬« safety study for menopause completes treatment phase and advances to data management & reporting phase

    Wednesday February 28th 2024

  • RheumaFinder announces investment by Novalis Biotech to revolutionize care for patients with rheumatic diseases

    Tuesday February 27th 2024